Montelukast in Seasonal Allergic Rhinitis: Fall 2001 Study (0476-240)
Status:
Completed
Trial end date:
2001-11-01
Target enrollment:
Participant gender:
Summary
This is a study to evaluate the treatment effect of montelukast 10 mg taken in the morning,
versus placebo, in patients with seasonal allergic rhinitis. Loratadine is included in the
study as an active control.